{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:21:30Z","timestamp":1770895290757,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["507652-16"],"award-info":[{"award-number":["507652-16"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.nucmedbio.2024.108908","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T14:53:16Z","timestamp":1711637596000},"page":"108908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Tracking the fate of bacteria-derived site-specific immunomodulators by positron emission tomography"],"prefix":"10.1016","volume":"132-133","author":[{"given":"Alexia","family":"Kirby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojm\u00edr","family":"Such\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Bazett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirin","family":"Kalyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Shuhendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2024.108908_bb0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00000441-189609000-00001","article-title":"The therapeutic value of mixed toxins of the streptococcus of erysipelas and bacillus prodigiosus in the treatment of inoperable malignant tumors","volume":"112","author":"Coley","year":"1896","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0010","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/1078-0432.CCR-12-1116","article-title":"Phase I clinical trial of mixed bacterial vaccine (Coley\u2019s toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity","volume":"18","author":"Karbach","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/CAD.0000000000000337","article-title":"Spontaneous regression of tumour and the role of microbial infection\u2013possibilities for cancer treatment","volume":"27","author":"Kucerova","year":"2016","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2014a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0025","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28926","article-title":"Attenuated listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis","volume":"3","author":"Lizotte","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0030","first-page":"5264","article-title":"Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine","volume":"59","author":"Pan","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.1201209","article-title":"Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated toxoplasma gondii protects against rechallenge","volume":"190","author":"Baird","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0040","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1158\/2326-6066.CIR-14-0235","article-title":"Attenuated toxoplasma gondii stimulates immunity to pancreatic cancer by manipulation of myeloid cell populations","volume":"3","author":"Sanders","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00262-009-0755-y","article-title":"Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responses","volume":"59","author":"Sottnik","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0050","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1245\/ASO.2005.01.011","article-title":"Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma","volume":"12","author":"Lascelles","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0055","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1158\/0008-5472.CAN-12-1974","article-title":"Avirulent toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment","volume":"73","author":"Baird","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0060","doi-asserted-by":"crossref","first-page":"8451728","DOI":"10.1155\/2016\/8451728","article-title":"Bacteria in cancer therapy: renaissance of an old concept","volume":"2016","author":"Felgner","year":"2016","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0065","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3389\/fimmu.2018.02211","article-title":"Immune stimulation using a gut microbe-based immunotherapy reduces disease pathology and improves barrier function in ulcerative colitis","volume":"9","author":"Sham","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0070","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1398875","article-title":"Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy","volume":"7","author":"Bazett","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-62735-z","article-title":"Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathology","volume":"10","author":"Kalyan","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0080","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.immuni.2015.05.011","article-title":"Bone-marrow-resident NK cells prime monocytes for regulatory function during infection","volume":"42","author":"Askenase","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12931-017-0577-y","article-title":"Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammation","volume":"18","author":"Bazett","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0090","doi-asserted-by":"crossref","first-page":"35338","DOI":"10.1038\/srep35338","article-title":"A novel microbe-based treatment that attenuates the inflammatory profile in a mouse model of allergic airway disease","volume":"6","author":"Bazett","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0095","first-page":"9","article-title":"Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis","author":"Wenzel","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02211","article-title":"Immune stimulation using a gut microbe-based immunotherapy reduces disease pathology and improves barrier function in ulcerative colitis","volume":"9","author":"Sham","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0105","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/jcag\/gwy054","article-title":"The impact of inflammatory bowel disease in Canada 2018: epidemiology","volume":"2","author":"Kaplan","year":"2018","journal-title":"J Can Assoc Gastroenterol"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study","volume":"395","author":"Ol\u00e9n","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0115","first-page":"438","article-title":"The present and future of inflammatory bowel disease treatment","volume":"12","author":"Sandborn","year":"2016","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0125","doi-asserted-by":"crossref","DOI":"10.7861\/clinmedicine.18-2-s41","article-title":"Recent advances in the management of lung cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Clin Med"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0130","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1038\/s41598-020-62735-z","article-title":"Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathology","volume":"10","author":"Kalyan","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C3CS60304K","article-title":"Matching chelators to radiometals for radiopharmaceuticals","volume":"43","author":"Price","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0140","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2967\/jnumed.108.060392","article-title":"Development and characterization of clinical-grade 89Zr-trastuzumab for HER2\/neu immunoPET imaging","volume":"50","author":"Dijkers","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep4.1834","article-title":"Dissecting the balance between metabolic and oncogenic functions of astrocyte-elevated gene-1\/metadherin","volume":"6","author":"Rajesh","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ebiom.2017.04.011","article-title":"Hyperglycemia-induced renal P2X7 receptor activation enhances diabetes-related injury","volume":"19","author":"Menzies","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2022.102147","article-title":"Deciphering mechanisms and implications of bacterial translocation in human health and disease","volume":"67","author":"Jin","year":"2022","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0160","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.cell.2012.07.021","article-title":"A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread","volume":"150","author":"Kastenm\u00fcller","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0165","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1073\/pnas.1715756115","article-title":"Neutrophils recruited through high endothelial venules of the lymph nodes via PNAd intercept disseminating Staphylococcus aureus","volume":"115","author":"Bogoslowski","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1084\/jem.127.2.263","article-title":"Antigens in immunity: XIV. Electron microscopic radioautographic studies of antigen capture in the lymph node medulla","volume":"127","author":"Nossal","year":"1968","journal-title":"J Exp Med"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06287","article-title":"Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells","volume":"450","author":"Junt","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0180","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1182\/blood-2005-03-1281","article-title":"Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes","volume":"106","author":"Abadie","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0185","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.immuni.2008.07.012","article-title":"Dynamics of neutrophil migration in lymph nodes during infection","volume":"29","author":"Chtanova","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0190","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1038\/ncomms8139","article-title":"Microbe-dependent lymphatic migration of neutrophils modulates lymphocyte proliferation in lymph nodes","volume":"6","author":"Hampton","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.nucmedbio.2024.108908_bb0195","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1172\/JCI124615","article-title":"The role of macrophages in the resolution of inflammation","volume":"129","author":"Watanabe","year":"2019","journal-title":"J Clin Invest"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T20:39:21Z","timestamp":1716669561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805124000349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":39,"alternative-id":["S0969805124000349"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108908","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tracking the fate of bacteria-derived site-specific immunomodulators by positron emission tomography","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108908"}}